欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子抑制剂 > Angiogenesis > AT9283

浏览历史

S81072

AT9283

源叶(MedMol) 99%
  • 英文名:
  • AT9283
  • 别名:
  • 1-cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea
  • CAS号:
  • 896466-04-9
  • 分子式:
  • C19H23N7O2
  • 分子量:
  • 381.44
  • 核磁/质谱:
品牌货号产品规格价格(RMB) 库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
源叶(MedMol) S81072-2mg 99% ¥510.00元 5 - - - EA 加入购物车
源叶(MedMol) S81072-5mg 99% ¥590.00元 6 - - - EA 加入购物车
源叶(MedMol) S81072-10mg 99% ¥1090.00元 6 - - - EA 加入购物车
源叶(MedMol) S81072-25mg 99% ¥1890.00元 6 - - - EA 加入购物车
源叶(MedMol) S81072-50mg 99% ¥3100.00元 预计交期:2-3天 - - - EA 加入购物车
源叶(MedMol) S81072-100mg 99% ¥6120.00元 预计交期:2-3天 - - - EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献

质检证书(COA)

摩尔浓度计算器

相关产品

  • 提示:详情请下载说明书。
  • 产品描述: AT9283 is a multi-targeted kinase inhibitor with potent activity against Aurora A/B, JAK2/3, Abl (T315I) and Flt3 (IC50s ranging from 1 to 30 nM). AT9283 inhibits growth and survival of multiple solid tumors in vitro and in vivo
  • 靶点: Aurora A:3 nM (IC50);Aurora B:3 nM (IC50);JAK3:1.1 nM (IC50);JAK2:1.2 nM (IC50);ABL(T315I):4 nM (IC50);Flt-3;Apoptosis; FLT; JAK; Bcr-Abl; AuroraKinase; Autophagy
  • 体内研究:
    In HCT116 human colon carcinoma xenograft bearing mice, AT9283 treatment (15 mg/kg and 20 mg/kg) for 16 days results in a significant tumor growth inhibition of 67% and 76%, respectively. In addition, AT9283 also exhibits a significantly longer half-life in tumors (2.5 hours) compared with plasma (0.5 hour) and modest oral bioavailability in mice. AT9283 (15 mg/kg) and docetaxel (10 mg/kg) alone has modest anti-tumor activity. T9283 at 20 mg/kg and AT9283 (15 or 20 mg/kg) plus docetaxel (10 mg/kg) demonstrate a statistically significant tumor growth inhibition and enhance survival inmouse xenograft model of mantle cell lymphoma. AT9283 (45 mg/kg, i.p.) inhibits tumor growth in mice. Two cycles of AT9283 45 mg/kg 14 hours after drug administration confirm decreased expression of phospho-Histone H3 and Aurora B in treated animals.
  • 参考文献:
    1. Howard S, et al. Fragment-Based Discovery of the Pyrazol-4-yl Urea (AT9283), a Multitargeted Kinase Inhibitor with Potent Aurora Kinase Activity. Journal of Medicinal Chemistry (2009), 52(2), 379-388. 2. Qi W, et al. AT9283, a novel aurora kinase inhibitor, suppresses tumor growth in aggressive B-cell lymphomas. Int J Cancer. 2012 Jun 15;130(12):2997-3005. 3. Santo L, et al. Antimyeloma activity of a multitargeted kinase inhibitor, AT9283, via potent Aurora kinase and STAT3 inhibition either alone or in combination with lenalidomide. Clin Cancer Res. 2011 May 15;17(10):3259-71
  • 溶解性: DMSO  :  ≥  100  mg/mL  (262.17  mM)
  • 保存条件: -20℃
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 2.622 ml 13.108 ml 26.216 ml
    5 mM 0.524 ml 2.622 ml 5.243 ml
    10 mM 0.262 ml 1.311 ml 2.622 ml
    50 mM 0.052 ml 0.262 ml 0.524 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。